Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

4579 Journals
3401 Congresses
7900+ Unique Records

Generics and Biosimilars Initiative Journal


Title Abbreviation
GaBi J
ISSN
2033-6403
Electronic ISSN
2033-6772
Readership
Academics, Biomedical Engineering Technologist, Biomedical Researchers, Clinical Pharmacists, Clinical Pharmacologists, Clinicians, Hospice Nurses, Hospital Administrators, Nurses, Patients, Pharmaceutical Benefits Managers, Pharmacists, Pharmacologists, Physicians, Physicians - Medicine, Policy Makers
Scope
GaBI Journal encompasses all aspects of generic and biosimilar medicines development and use, from fundamental research up to clinical application and policies. The mission is to provide an independent, high quality, authoritative, and peer reviewed platform for the publication of scientific articles concerning any aspect of the research into and development of cost-effective medicines, irrespective of their source. GaBI will thus make information on pharmaceutical innovation and developments in generic and biosimilar medicines accessible to everyone, including physicians, pharmacists and nurses, patients/consumers, drug developers, third-party payers, legislators and assessors. The scope is broad and of interest and relevance to professionals active in clinical practice, pharmaceutical science and policy. Materials include high quality research reports, literature reviews and case studies, all of which are peer reviewed. All aspects of generic and biosimilar medicines, covering areas in clinical, fundamental, technical, manufacturing, bi-processing, economic and social aspects of pharmaceuticals and therapeutics are welcome. In addition, high quality work submitted in other formats, for example, scientific and evidence-based commentaries, may also be considered. In all cases, the emphasis is on quality, originality and knowledge contribution to those involved in health care.
Sponsoring Association(s)
Generics and Biosimilars Initiative (GaBi)
Publisher Name
Pro Pharma Communications International
To see more details about Generics and Biosimilars Initiative Journal, Subscribe Now!
Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library